A Practical GuideBy
- Luis Raez, MD, FACP, FCCP, Associate Professor of Medicine, Epidemiology and Public Health; Director, Hematology/Oncology Clinics and Chemotherapy Unit (CTU), Co-Leader Thoracic Oncology Group, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA
- Orlando Silva, MD, JD, FACP, FCLM, Director of Breast Cancer Education, Assistant Professor of Clinical Medicine, Leonard M. Miller School of Medicine, University of Miami, Miami, FL
This handbook is written to provide a 'bedside' reference for the practising oncologist, as well as a compendium of lung cancer information useful to thoracic surgeons, pulmonologists, respiratory medicine specialists, clinical researchers and educators, medical students and nurses. The book is written in outline format to provide the reader with quick and easy access to information on the major trials, landmark articles and reviews in lung cancer. The results of important clinical trials are summarised in 5-10 lines, with key data including: whether or not randomised; number of subjects; study periods; median follow-up; dosages; results; limitations and conclusions. In addition, there is a comprehensive index so that specific information can be quickly found.
Medical oncologists, radiation oncologists, cancer surgeons, thoracic surgeons, pulmonologists, respiratory medicine specialists, oncology fellows and trainees, medical students, nurses, clinical researchers and educators.
Paperback, 272 Pages
- History of lung cancer. Epidemiology of lung cancer. Screening for lung cancer. Imaging in lung cancer. Diagnostic techniques in lung cancer. Lung pathology. Surgery in non-small-cell lung cancer. Neoadjuvant therapy for non-small-cell lung cancer . Adjuvant chemotherapy for non-small-cell lung cancer. Combined modality therapy for locally advanced non-small-cell lung cancer. Chemotherapy in advanced non-small-cell lung cancer. Surgery in small-cell lung cancer. Chemotherapy in limited-disease, small-cell lung cancer. Radiation therapy for limited-disease, small-cell lung cancer. Extensive-disease, small-cell lung cancer. Malignant mesothelioma. Lung cancer in the elderly population and poor performance status. Targeted therapy in non-small-cell lung cancer. Vaccine therapy in lung cancer. Palliative treatment in lung cancer. Lung cancer in women.